Onconetix
ONCO
6 hedge funds and large institutions have $73.9K invested in Onconetix in 2026 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
197% more capital invested
Capital invested by funds: $24.9K → $73.9K (+$49K)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
20% more funds holding
Funds holding: 5 → 6 (+1)
3.6% less ownership
Funds ownership: 5.38% → 1.77% (-3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$235K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$62K |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$1.1K |
| 4 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
+$458 |
| 5 |
Morgan Stanley
New York
|
+$96 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.7K |
| 2 |
Citigroup
New York
|
-$2.56K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.35K |
ONCO Hedge Fund Activity: Q2 2026 in Review
6 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q2 2026, worth a combined $73.9K — up 197% from $24.9K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ONCO positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $235K. The largest seller was Geode Capital Management, exiting entirely with an estimated $17.7K sold.
- 6 institutional investors held Onconetix (ONCO) as of Q2 2026, up from 5 in Q1 2026.
- Funds reported $73.9K of Onconetix stock for Q2 2026, up 197% quarter-over-quarter.
- 4 funds opened new Onconetix positions in Q2 2026 and 3 closed out, a net change of +1 holder.
- The largest Onconetix buyer in Q2 2026 was HRT Financial, an estimated $235K added.
- The largest Onconetix seller in Q2 2026 was Geode Capital Management, an estimated $17.7K sold.
Based on aggregated 13F filings for Q2 2026.